Pharmaceuticals Sector - Solvay

Summary fi nancial statements of Solvay S.A.
The annual fi nancial statements of Solvay S.A. are presented in summary format below. In accordance with the
Companies Code, the annual fi nancial statements of Solvay S.A., the management report and the statutory auditor’s
report will be deposited with the National Bank of Belgium. These documents are also available on request from:
Solvay S.A.
Rue du Prince Albert 33
B -1050 Brussels
The Statutory Auditor has expressed a reserve with regard to the decision, mentioned in the management report, to
maintain the value of Solvay Pharmaceuticals Sàrl at the historical value of the participating investments contributed
to it. The reserve relates solely to the accounts of Solvay S.A. and does not in any way concern the Group’s
consolidated accounts.
Balance sheet of Solvay S.A.
EUR million at December 31
ASSETS
2004 2005
Fixed assets 4 350 3 385
Start-up expenses and intangible assets 69 69
Tangible assets 90 66
Financial assets 4 191 3 250
Current assets 2 550 2 782
Inventories 21 15
Trade receivables 134 121
Other receivables 870 1 485
Short-term investments and cash equivalents 1 525 1 161
Total assets
SHAREHOLDERS’ EQUITY AND LIABILITIES
6 900 6 167
Shareholders’ equity 3 594 3 765
Capital 1 269 1 270
Other equity 1 962 1 966
Net income carried forward 363 529
Investment grants
Provisions and deferred taxes 337 356
Financial debt 2 532 1 578
- due in more than one year 1 517 815
- due within one year 1 015 763
Trade liabilities 91 120
Other liabilities 346 348
Total shareholders’ equity and liabilities 6 900 6 167
103
Solvay Global Annual Report 2005